Groove Botanicals, Inc. (GRVE)
OTCMKTS · Delayed Price · Currency is USD
0.0041
+0.0001 (2.50%)
At close: Aug 7, 2026
Groove Botanicals Balance Sheet
Financials in millions USD. Fiscal year is April - March.
Millions USD. Fiscal year is Apr - Mar.
Assets
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Equivalents | 0 | 0 | 0 | 0 | 0 | 0.05 |
Cash & Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0.05 |
Cash Growth | -45.41% | -26.45% | 20.97% | -63.03% | -90.59% | 513.50% |
Other Receivables | - | - | - | - | - | 0 |
Receivables | - | - | - | - | - | 0 |
Prepaid Expenses | 0 | 0 | 0 | 0 | 0 | - |
Total Current Assets | 0 | 0 | 0 | 0 | 0.01 | 0.05 |
Total Assets | 0 | 0 | 0 | 0 | 0.01 | 0.05 |
Liabilities
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Accounts Payable | 0.06 | 0.07 | 0.07 | 0.09 | 0.04 | 0.05 |
Accrued Expenses | - | - | - | - | 0.01 | 0.01 |
Short-Term Debt | - | - | - | - | 0.09 | 0.16 |
Other Current Liabilities | 1.48 | 1.4 | 1.05 | 0.67 | 0.3 | 0.29 |
Total Current Liabilities | 1.55 | 1.47 | 1.11 | 0.76 | 0.44 | 0.5 |
Total Liabilities | 1.55 | 1.47 | 1.11 | 0.76 | 0.44 | 0.5 |
Shareholders' Equity
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Common Stock | 0.06 | 0.06 | 0.06 | 0.06 | 0.06 | 0.05 |
Additional Paid-In Capital | 34.03 | 34.03 | 34.03 | 34.03 | 33.93 | 33.8 |
Retained Earnings | -35.63 | -35.55 | -35.2 | -34.85 | -34.43 | -34.31 |
Comprehensive Income & Other | - | - | - | - | - | 0 |
Total Common Equity | -1.54 | -1.47 | -1.11 | -0.76 | -0.44 | -0.46 |
Shareholders' Equity | -1.54 | -1.47 | -1.11 | -0.76 | -0.44 | -0.45 |
Total Liabilities & Equity | 0 | 0 | 0 | 0 | 0.01 | 0.05 |
Additional Metrics
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Total Debt | - | - | - | - | 0.09 | 0.16 |
Net Cash (Debt) | 0 | 0 | 0 | 0 | -0.09 | -0.12 |
Net Cash Growth | -45.41% | -26.45% | 20.97% | - | - | - |
Net Cash Per Share | 0.00 | 0.00 | 0.00 | 0.00 | -0.00 | -0.00 |
Filing Date Shares Outstanding | 59.64 | 59.64 | 59.64 | 59.64 | 57.64 | 49.19 |
Total Common Shares Outstanding | 59.64 | 59.64 | 59.64 | 59.64 | 57.64 | 49.19 |
Working Capital | -1.54 | -1.47 | -1.11 | -0.76 | -0.44 | -0.45 |
Book Value Per Share | -0.03 | -0.02 | -0.02 | -0.01 | -0.01 | -0.01 |
Tangible Book Value | -1.54 | -1.47 | -1.11 | -0.76 | -0.44 | -0.46 |
Tangible Book Value Per Share | -0.03 | -0.02 | -0.02 | -0.01 | -0.01 | -0.01 |